Effect of Wenxia Changfu Formula Combined With Cisplatin Reversing Non-Small Cell Lung Cancer Cell Adhesion-Mediated Drug Resistance

Overview

Journal Front Pharmacol

Date 2020 Oct 12

PMID 33041787

Citations 7

Authors

Meng-Ran Wang

Rui-Jie Chen

Fang Zhao

Hong-Hua Zhang

Qian-Yu Bi

Ya-Nan Zhang

Yin-Qiang Zhang

Zhi-Chun Wu

Xu-Ming Ji

Affiliations

Soon will be listed here.

Abstract

Non-small cell lung cancer (NSCLC), the major form of primary lung cancer, is a common cause of cancer-related death worldwide. Cell adhesion-mediated drug resistance (CAM-DR), a form of chemotherapy resistance, has been reported to confer resistance to various chemotherapeutic agents. Integrin β1 signaling plays an important role in CAM-DR and has been proposed as a potential target for NSCLC. Wenxia Changfu Formula (WCF) is a Traditional Chinese Compound Prescription for the intervention treatment of NSCLC combined with cisplatin (DDP). This study aims to investigate the effect and mechanism of WCF combined with DDP in reversing CAM-DR. Firstly, the chemical profile of WCF was characterized by UPLC/Q-TOF-MS analysis. A total of 237 compounds with mzCloud Best Match of greater than 70 were identified by using the online database mzCloud. Secondly, we established A549 three-dimensional(3D) cells cultured in vitro and nude mice xenografts models of the A549 cell line with Integrin β1 overexpression. , the cell viability, migration and adhesion were measured though MTT Assay, Wound Healing Assay and Cell Adhesion Assay, the Integrin β1 expression of the A549 cells was assessed through immunocytochemistry; , the transplanted tumor morphology and the colocalization of Integrin β1 and its ligands were tested by HE staining and immunofluorescence. As a result, we found that the combination effectively reduced cell viability, suppressed migration and adhesion, and downregulated the protein level of Integrin β1 in three-dimensional cultured A549 cells. And the combination of WCF with DDP significantly inhibited tumor growth, increased organelle vacuolations and decreased colocalization of Integrin β1 and its ligands including fibulin-2 and laminin. Taken together, our results confirm that the combination of WCF with DDP could reverse the lung cancer CAM-DR through the Integrin β1 signaling pathway.

Citing Articles

A Novel Competing Endogenous RNA Network Reveals Potential Mechanisms and Biomarkers of Chemoresistance in Lung Adenocarcinoma.

Liu W, Zhou H, Qi Y, Wang P, Ning S, Huang Y J Cancer. 2025; 16(3):720-734.

PMID: 39781361 PMC: 11705065. DOI: 10.7150/jca.102148.

Cisplatin-Based Combination Therapy for Enhanced Cancer Treatment.

Li Q, Chen S, Wang X, Cai J, Huang H, Tang S Curr Drug Targets. 2024; 25(7):473-491.

PMID: 38591210 DOI: 10.2174/0113894501294182240401060343.

Jiedu Fuzheng decoction improves the proliferation, migration, invasion and EMT of non-small cell lung cancer via the Wnt/β-catenin pathway.

Fang F, Jin X, Meng J, He J, Wang J, Wang C Cell Div. 2023; 18(1):22.

PMID: 38104091 PMC: 10725601. DOI: 10.1186/s13008-023-00105-7.

Diosbulbin C, a novel active ingredient in Dioscorea bulbifera L. extract, inhibits lung cancer cell proliferation by inducing G0/G1 phase cell cycle arrest.

Zhu Z, Liu Y, Zeng J, Ren S, Wei L, Wang F BMC Complement Med Ther. 2023; 23(1):436.

PMID: 38049779 PMC: 10694954. DOI: 10.1186/s12906-023-04245-9.

Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future.

Huang J, Li J, Ma L, Xu D, Wang P, Li L Integr Cancer Ther. 2022; 21:15347354221144312.

PMID: 36567455 PMC: 9806388. DOI: 10.1177/15347354221144312.

References

Xu Z, Zou L, Ma G, Wu X, Huang F, Feng T . Integrin β1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma. Am J Cancer Res. 2017; 7(3):531-542. PMC: 5385641. View

Russi S, Verma H, Laurino S, Mazzone P, Storto G, Nardelli A . Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. Int J Mol Sci. 2019; 20(15). PMC: 6695752. DOI: 10.3390/ijms20153736. View

Hoarau-Vechot J, Rafii A, Touboul C, Pasquier J . Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?. Int J Mol Sci. 2018; 19(1). PMC: 5796130. DOI: 10.3390/ijms19010181. View

Kaseda K . Recent and Current Advances in FDG-PET Imaging within the Field of Clinical Oncology in NSCLC: A Review of the Literature. Diagnostics (Basel). 2020; 10(8). PMC: 7459495. DOI: 10.3390/diagnostics10080561. View

Fontanil T, Rua S, Llamazares M, Moncada-Pazos A, Quiros P, Garcia-Suarez O . Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells. Oncotarget. 2014; 5(5):1253-64. PMC: 4012729. DOI: 10.18632/oncotarget.1690. View

Li Q, Chow A, Mattingly R . Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors. J Pharmacol Exp Ther. 2009; 332(3):821-8. PMC: 2835447. DOI: 10.1124/jpet.109.160390. View

Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y . Role of tumor microenvironment in tumorigenesis. J Cancer. 2017; 8(5):761-773. PMC: 5381164. DOI: 10.7150/jca.17648. View

Jakubzig B, Baltes F, Henze S, Schlesinger M, Bendas G . Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells-Deciphering Novel Potential Targets for a Cell Sensitization. Cancers (Basel). 2018; 10(12). PMC: 6315379. DOI: 10.3390/cancers10120495. View

Da Ros M, De Gregorio V, Iorio A, Giunti L, Guidi M, de Martino M . Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier. Int J Mol Sci. 2018; 19(10). PMC: 6213072. DOI: 10.3390/ijms19102879. View

10.

Fetah K, Dipardo B, Kongadzem E, Tomlinson J, Elzagheid A, Elmusrati M . Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration. Small. 2019; 15(50):e1901985. PMC: 6929691. DOI: 10.1002/smll.201901985. View

11.

Ji X, Ouyang B, Liu H, Liu G, Wu Z, Yu H . In vitro and in vivo inhibitory effect of the combination of Wenxia Changfu formula [see text] with cisplatin in non-small cell lung cancer. Chin J Integr Med. 2011; 17(12):908-16. DOI: 10.1007/s11655-011-0934-5. View

12.

Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber J, Vogel G . Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells. PLoS One. 2014; 9(3):e92511. PMC: 3963897. DOI: 10.1371/journal.pone.0092511. View

13.

Baltes F, Pfeifer V, Silbermann K, Caspers J, Wantoch von Rekowski K, Schlesinger M . β-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters. Biochim Biophys Acta Mol Cell Res. 2020; 1867(5):118663. DOI: 10.1016/j.bbamcr.2020.118663. View

14.

Duma N, Santana-Davila R, Molina J . Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019; 94(8):1623-1640. DOI: 10.1016/j.mayocp.2019.01.013. View

15.

Kletzmayr A, Clement Frey F, Zimmermann M, Eberli D, Millan C . An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody-Based Therapeutics in Overcoming Chemoresistance. Biotechnol J. 2020; 15(5):e1900439. DOI: 10.1002/biot.201900439. View

16.

Gomes L, Rocha C, Martins D, Fiore A, Sarti Kinker G, Bruni-Cardoso A . ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation. Cell Death Dis. 2019; 10(6):459. PMC: 6561919. DOI: 10.1038/s41419-019-1689-8. View

17.

Yang X, Wang S, Yu W, Zheng Y, Wu Y . Inhibition of ITGB1 enhance the anti-tumor effect of cetuximab in colorectal cancer cell. Medicine (Baltimore). 2020; 99(27):e20944. PMC: 7337548. DOI: 10.1097/MD.0000000000020944. View

18.

Li X, Chu S, Lin M, Gao Y, Liu Y, Yang S . Anticancer property of ginsenoside Rh2 from ginseng. Eur J Med Chem. 2020; 203:112627. DOI: 10.1016/j.ejmech.2020.112627. View

19.

Shen J, Xu J, Chen B, Ma D, Chen Z, Li J . Elevated integrin α6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics. J Cancer Res Clin Oncol. 2019; 145(7):1681-1693. DOI: 10.1007/s00432-019-02907-1. View

20.

Virumbrales-Munoz M, Ayuso J, Lacueva A, Randelovic T, Livingston M, Beebe D . Enabling cell recovery from 3D cell culture microfluidic devices for tumour microenvironment biomarker profiling. Sci Rep. 2019; 9(1):6199. PMC: 6470149. DOI: 10.1038/s41598-019-42529-8. View